Monoclonal antibody against CD52, provided in intravenous or subcutaneous injectable form for chronic lymphocytic leukemia and T-cell lymphomas. Utilized by hematology-oncology units in medical centers, supplied by immunology-focused pharmaceutical firms and healthcare distributors.